NS · Pharmaceuticals
Pharmaceuticals & Biotechnology
Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $590.70M, P/E ratio is 21.35, net margin is 4.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) has a reported market cap of $590.70M (data as of 2026-07-10).
The price-to-earnings (P/E) ratio for Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) is 21.35 (data as of 2026-07-10).
Dividend yield is not available in the current snapshot for Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM). Check the MyAverix Finance app for the latest dividend data.
Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
BIOFILCHEM is listed on NS.
Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) reports a net margin of 4.1% (data as of 2026-07-10).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.